Evolocumab
Amgen
['cardio']
 yellow iii study: stable cad plaque morphology improved by pcsk9 inhibitors #acc23 #acc2023 #cardiotwitter #medtwitter #escyoung 
🇮🇹 🇪🇺 MD | PhD | Assistant Professor and Cardiologist at @unicampania | @ESC_Journals | #EHJPharmacotherapy Twitter Editor 💊